424 Capital Exits Healthcare Tech Firm Reverba in New Deal
Boston-area private equity firm 424 Capital has completed a successful exit of its portfolio company Reverba, a tech-enabled services firm.
424 Capital, a Wakefield, Massachusetts-based lower middle market private equity firm, announced Wednesday it has completed the exit of its investment in Reverba, marking a successful conclusion to its ownership stake in the healthcare and energy transition-focused company.
The firm, which concentrates on tech-enabled services businesses operating in the healthcare and energy transition sectors, did not disclose financial terms of the transaction, including sale price or the identity of the acquiring party.
Read more Abu Dhabi Finance Week 2026 Launches Most Ambitious Program Yet →
424 Capital describes itself as a specialist investor in the lower middle market, a segment of the private equity landscape typically targeting companies with relatively modest revenue and enterprise values compared to large-cap buyout targets. The firm's dual sector focus — healthcare and energy transition — reflects broader investor appetite for technology-driven service businesses in regulated and growth-oriented industries.
The Reverba exit adds to the growing roster of lower middle market deals completed in the healthcare technology space, a segment that has attracted sustained private equity interest as providers and payers seek efficiency through outsourced, tech-enabled solutions. No further operational details about Reverba's business or the timeline of 424 Capital's holding period were made available in the announcement.
Continue reading at All Financial Services & Investing.